Literature DB >> 23470603

Violence in schizophrenia and bipolar disorder.

Jan Volavka1.   

Abstract

BACKGROUND: Although most psychiatric patients are not violent, serious mental illness is associated with increased risk of violent behavior. Most of the evidence available pertains to schizophrenia and bipolar disorder.
METHODS: MEDLINE data base was searched for articles published between 1966 and November 2012 using the combination of key words 'schizophrenia' or 'bipolar disorder' with 'aggression' or 'violence'. For the treatment searches, generic names were used in combination with key words 'schizophrenia' or 'bipolar disorder' and 'aggression' No language constraint was applied. Only articles dealing with adults were included. The lists of references were searched manually to find additional articles.
RESULTS: There were statistically significant increases of risk of violence in schizophrenia and in bipolar disorder in comparison with general population. The evidence suggests that the risk of violence is greater in bipolar disorder than in schizophrenia. Most of the violence in bipolar disorder occurs during the manic phase. The risk of violence in schizophrenia and bipolar disorder is increased by comorbid substance use disorder. Violence among adults with schizophrenia may follow at least two distinct pathways-one associated with antisocial conduct, and another associated with the acute psychopathology of schizophrenia. Clozapine is the most effective treatment of aggressive behavior in schizophrenia. Emerging evidence suggests that olanzapine may be the second line of treatment. Treatment adherence is of key importance. Non-pharmacological methods of treatment of aggression in schizophrenia and bipolar disorder are increasingly important. Cognitive behavioral approaches appear to be effective in cases where pharmacotherapy alone does not suffice.
CONCLUSIONS: Violent behavior of patients with schizophrenia and bipolar disorder is a public health problem. Pharmacological and non-pharmacological approaches should be used to treat not only violent behavior, but also contributing comorbidities such as substance abuse and personality disorders. Treatment adherence is very important for successful management of violent behavior.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23470603

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  29 in total

Review 1.  Guidelines for the Pharmacotherapy of Schizophrenia in Adults.

Authors:  Gary Remington; Donald Addington; William Honer; Zahinoor Ismail; Thomas Raedler; Michael Teehan
Journal:  Can J Psychiatry       Date:  2017-07-13       Impact factor: 4.356

2.  Increased risk of fracture in patients with bipolar disorder: a nationwide cohort study.

Authors:  Chih-Chao Hsu; Yi-Chao Hsu; Kuang-Hsi Chang; Chang-Yin Lee; Lee-Won Chong; Yu-Chiao Wang; Chung-Y Hsu; Chia-Hung Kao
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-05-30       Impact factor: 4.328

3.  Role of CB2 receptors in social and aggressive behavior in male mice.

Authors:  Marta Rodríguez-Arias; Francisco Navarrete; M Carmen Blanco-Gandia; M Carmen Arenas; María A Aguilar; Adrián Bartoll-Andrés; Olga Valverde; José Miñarro; Jorge Manzanares
Journal:  Psychopharmacology (Berl)       Date:  2015-04-29       Impact factor: 4.530

4.  Bipolar disorder and criminal offending: a data linkage study.

Authors:  Elizabeth Daff; Stuart D M Thomas
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-04       Impact factor: 4.328

Review 5.  Regulation of aggressive behaviors by nicotinic acetylcholine receptors: Animal models, human genetics, and clinical studies.

Authors:  Alan S Lewis; Marina R Picciotto
Journal:  Neuropharmacology       Date:  2019-12-26       Impact factor: 5.250

6.  A cross sectional study of prevalence and correlates of current and past risks in schizophrenia.

Authors:  Kiran Jakhar; Triptish Bhatia; Rahul Saha; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2015-02-03

7.  Peripheral Inflammatory Parameters in Patients with Antisocial Personality Disorder.

Authors:  Gülay Taşci; Şüheda Kaya; Sevda Korkmaz; Murad Atmaca
Journal:  Noro Psikiyatr Ars       Date:  2021-07-27       Impact factor: 1.339

Review 8.  Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review.

Authors:  Diane Merino; Arnaud Fernandez; Alexandre O Gérard; Nouha Ben Othman; Fanny Rocher; Florence Askenazy; Céline Verstuyft; Milou-Daniel Drici; Susanne Thümmler
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-14

9.  High seroprevalence of Toxoplasma gondii infection in inmates: A case control study in Durango City, Mexico.

Authors:  C Alvarado-Esquivel; J Hernández-Tinoco; L F Sánchez-Anguiano; A Ramos-Nevárez; S M Cerrillo-Soto; L Sáenz-Soto; O Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

10.  Mental illness and the risk of self- and other-directed aggression: Results from the National Survey on Drug Use and Health.

Authors:  Elias Ghossoub; Michele Cherro; Carla Akil; Yara Gharzeddine
Journal:  J Psychiatr Res       Date:  2020-10-16       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.